New pill shows promise for Tough-to-Treat lymphoma
Disease control
Completed
This study tested an experimental drug called AZD4205 in 57 adults with a rare type of blood cancer (peripheral T-cell lymphoma) that had returned or stopped responding to prior therapy. The goal was to see if the drug could shrink tumors and how safe it was. Participants took a …
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated May 17, 2026 02:46 UTC